Acadian Asset Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-16,071
Closed -$237K – 1617
2023
Q4
$237K Buy
16,071
+7,503
+88% +$85K ﹤0.01% 1204
2023
Q3
$95K Buy
+8,568
New +$99.5K ﹤0.01% 1313
2023
Q2
– Sell
-9,437
Closed -$88K – 1776
2023
Q1
$88K Sell
9,437
-1,595
-14% -$18.8K ﹤0.01% 1422
2022
Q4
$134K Buy
11,032
+7,765
+238% +$96.8K ﹤0.01% 1371
2022
Q3
$40K Sell
3,267
-36,581
-92% -$639K ﹤0.01% 1523
2022
Q2
$782K Sell
39,848
-73,877
-65% -$1.75M ﹤0.01% 867
2022
Q1
$2.96M Buy
+113,725
New +$3.03M 0.01% 572
2021
Q4
– Sell
-15,200
Closed -$483K – 1718
2021
Q3
$483K Sell
15,200
-20,493
-57% -$688K ﹤0.01% 1053
2021
Q2
$1.24M Buy
35,693
+25,823
+262% +$852K ﹤0.01% 853
2021
Q1
$291K Buy
+9,870
New +$304K ﹤0.01% 1373
2020
Q4
– Sell
-1,469
Closed -$41K – 2232
2020
Q3
$41K Buy
+1,469
New +$37.2K ﹤0.01% 1904

Other funds holding ELAN

Acadian Asset Management's ELAN Position: Q1 2024 in Review

Acadian Asset Management sold out of Elanco Animal Health (ELAN) in Q1 2024, closing a stake of 16,071 shares — an estimated $237K sold.

Acadian Asset Management first reported a position in ELAN in Q3 2020 and held it in 11 quarters. The position peaked at $2.96M in Q1 2022. 374 funds tracked by Wall St. Rank hold ELAN as of Q1 2024.

  • Acadian Asset Management reported no remaining Elanco Animal Health position as of Q1 2024 after selling out during the quarter.
  • Acadian Asset Management sold 16,071 Elanco Animal Health shares in Q1 2024, an estimated $237K.
  • Acadian Asset Management first reported a position in Elanco Animal Health in Q3 2020 and held it in 11 quarters.
  • Acadian Asset Management's Elanco Animal Health position peaked at $2.96M in Q1 2022.
  • 374 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2024.

Based on Acadian Asset Management's 13F filing for Q1 2024, filed 10 May 2024.